Literature DB >> 12893827

Amyloid beta protein precursor (AbetaPP), but not AbetaPP-like protein 2, is bridged to the kinesin light chain by the scaffold protein JNK-interacting protein 1.

Shuji Matsuda1, Yukiko Matsuda, Luciano D'Adamio.   

Abstract

Proteolytic processing of amyloid beta protein precursor (AbetaPP) generates peptides that regulate normal cell signaling and are implicated in Alzheimer's disease pathogenesis. AbetaPP processing also occurs in nerve processes where AbetaPP is transported from the cell body by kinesin-I, a microtubule motor composed of two kinesin heavy chain and two kinesin light chain (Klc) subunits. AbetaPP transport is supposedly mediated by the direct AbetaPP-Klc1 interaction. Here we demonstrate that the AbetaPP-Klc1 interaction is not direct but is mediated by JNK-interacting protein 1 (JIP1). The phosphotyrosine binding domain of JIP1 binds the cytoplasmic tail of AbetaPP, whereas the JIP1 C-terminal region interacts with the tetratrico-peptide repeats of Klc1. We also show that JIP1 does not bridge the AbetaPP gene family member AbetaPP-like protein 2, APLP2, to Klc1. These results support a model where JIP1 mediates the interaction of AbetaPP to the motor protein kinesin-I and that this JIP1 function is unique for AbetaPP relative to its family member APLP2. Our data suggest that kinesin-I-dependent neuronal AbetaPP transport, which controls AbetaPP processing, may be regulated by JIP1.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12893827     DOI: 10.1074/jbc.M304379200

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  45 in total

Review 1.  Axonal transport of APP and the spatial regulation of APP cleavage and function in neuronal cells.

Authors:  Silke Brunholz; Sangram Sisodia; Alfredo Lorenzo; Carole Deyts; Stefan Kins; Gerardo Morfini
Journal:  Exp Brain Res       Date:  2011-09-30       Impact factor: 1.972

Review 2.  Unconventional functions of microtubule motors.

Authors:  Virgil Muresan; Zoia Muresan
Journal:  Arch Biochem Biophys       Date:  2012-01-28       Impact factor: 4.013

3.  JIP1 and JIP3 cooperate to mediate TrkB anterograde axonal transport by activating kinesin-1.

Authors:  Tao Sun; Yuan Li; Ting Li; Huixian Ma; Yunyun Guo; Xingyu Jiang; Ming Hou; Shuhong Huang; Zheyu Chen
Journal:  Cell Mol Life Sci       Date:  2017-06-21       Impact factor: 9.261

Review 4.  The axonal transport of mitochondria.

Authors:  Peter J Hollenbeck; William M Saxton
Journal:  J Cell Sci       Date:  2005-12-01       Impact factor: 5.285

Review 5.  The amyloid-beta precursor protein: integrating structure with biological function.

Authors:  Constanze Reinhard; Sébastien S Hébert; Bart De Strooper
Journal:  EMBO J       Date:  2005-10-27       Impact factor: 11.598

6.  Role of phosphatidylinositol clathrin assembly lymphoid-myeloid leukemia (PICALM) in intracellular amyloid precursor protein (APP) processing and amyloid plaque pathogenesis.

Authors:  Qingli Xiao; So-Chon Gil; Ping Yan; Yan Wang; Sharon Han; Ernie Gonzales; Ronaldo Perez; John R Cirrito; Jin-Moo Lee
Journal:  J Biol Chem       Date:  2012-04-26       Impact factor: 5.157

7.  Interactions of S100A2 and S100A6 with the tetratricopeptide repeat proteins, Hsp90/Hsp70-organizing protein and kinesin light chain.

Authors:  Seiko Shimamoto; Maki Takata; Masaaki Tokuda; Fumikazu Oohira; Hiroshi Tokumitsu; Ryoji Kobayashi
Journal:  J Biol Chem       Date:  2008-07-31       Impact factor: 5.157

8.  Subpixel colocalization reveals amyloid precursor protein-dependent kinesin-1 and dynein association with axonal vesicles.

Authors:  Lukasz Szpankowski; Sandra E Encalada; Lawrence S B Goldstein
Journal:  Proc Natl Acad Sci U S A       Date:  2012-05-11       Impact factor: 11.205

Review 9.  Role of HIV in amyloid metabolism.

Authors:  Mario Ortega; Beau M Ances
Journal:  J Neuroimmune Pharmacol       Date:  2014-05-10       Impact factor: 4.147

10.  CD74 interacts with APP and suppresses the production of Abeta.

Authors:  Shuji Matsuda; Yukiko Matsuda; Luciano D'Adamio
Journal:  Mol Neurodegener       Date:  2009-10-22       Impact factor: 14.195

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.